<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-molecules-25-04796">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ko</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Sohn</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Jang</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Ahn</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>D.G.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>Y.C.</given-names>
   </name>
   <name>
    <surname>Oh</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-small ka, CyrillicB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells</article-title>
  <source>Chem. Biol. Interact.</source>
  <year>2016</year>
  <volume>244</volume>
  <fpage>16</fpage>
  <lpage>26</lpage>
  <pub-id pub-id-type="doi">10.1016/j.cbi.2015.11.024</pub-id>
  <?supplied-pmid 26620692?>
  <pub-id pub-id-type="pmid">26620692</pub-id>
 </element-citation>
</ref>
